The Enterprise Value as of April 2026 (TTM) for Acumen Pharmaceuticals, Inc. (ABOS) is 119.06M

According to Acumen Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 119.06M. This represents a change of 48.06% compared to the average of 80.42M of the last 4 quarters.

Acumen Pharmaceuticals, Inc. (ABOS) Historical Enterprise Value (quarterly & annually)

How has ABOS Enterprise Value performed in the past?

The mean historical Enterprise Value of Acumen Pharmaceuticals, Inc. over the last ten years is 239.64M. The current 119.06M Enterprise Value has changed 4.87% with respect to the historical average. Over the past ten years (40 quarters), ABOS's Enterprise Value was at its highest in in the June 2021 quarter at 708.09M. The Enterprise Value was at its lowest in in the March 2020 quarter at 0.

Acumen Pharmaceuticals, Inc. (ABOS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Acumen Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Acumen Pharmaceuticals, Inc. (ABOS) Average Enterprise Value

How has ABOS Enterprise Value performed in the past?

The current Enterprise Value of Acumen Pharmaceuticals, Inc. (ABOS) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Acumen Pharmaceuticals, Inc. (ABOS) Enterprise Value vs. Peers

How is ABOS’s Enterprise Value compared to its peers?

Acumen Pharmaceuticals, Inc.’s Enterprise Value is greater than Inovio Pharmaceuticals, Inc. (25.12M), less than Opus Genetics, Inc. (288.36M), less than Agenus Inc. (479.35M), less than Alector, Inc. (224.26M), greater than Seer, Inc. (82.44M), greater than Seres Therapeutics, Inc. (104.78M), less than Fate Therapeutics, Inc. (175.39M), greater than VistaGen Therapeutics, Inc. (-26414732.00), greater than Spero Therapeutics, Inc. (109.10M), greater than Actuate Therapeutics Inc (55.53M),

Build a custom stock screener for Acumen Pharmaceuticals, Inc. (ABOS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acumen Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Acumen Pharmaceuticals, Inc. (ABOS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Acumen Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.